Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 12(1): 2130, 2021 04 09.
Article in English | MEDLINE | ID: mdl-33837217

ABSTRACT

Mito-SEPs are small open reading frame-encoded peptides that localize to the mitochondria to regulate metabolism. Motivated by an intriguing negative association between mito-SEPs and inflammation, here we screen for mito-SEPs that modify inflammatory outcomes and report a mito-SEP named "Modulator of cytochrome C oxidase during Inflammation" (MOCCI) that is upregulated during inflammation and infection to promote host-protective resolution. MOCCI, a paralog of the NDUFA4 subunit of cytochrome C oxidase (Complex IV), replaces NDUFA4 in Complex IV during inflammation to lower mitochondrial membrane potential and reduce ROS production, leading to cyto-protection and dampened immune response. The MOCCI transcript also generates miR-147b, which targets the NDUFA4 mRNA with similar immune dampening effects as MOCCI, but simultaneously enhances RIG-I/MDA-5-mediated viral immunity. Our work uncovers a dual-component pleiotropic regulation of host inflammation and immunity by MOCCI (C15ORF48) for safeguarding the host during infection and inflammation.


Subject(s)
Electron Transport Complex IV/genetics , Genetic Pleiotropy/immunology , Inflammation/immunology , MicroRNAs/metabolism , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Cell Line , Electron Transport Complex IV/metabolism , Gene Knockout Techniques , Humans , Inflammation/genetics , Inflammation/pathology , Membrane Potential, Mitochondrial/immunology , MicroRNAs/genetics , Mitochondria/immunology , Mitochondria/pathology , Primary Cell Culture , Reactive Oxygen Species/metabolism , Up-Regulation/immunology
2.
Sci Adv ; 7(12)2021 03.
Article in English | MEDLINE | ID: mdl-33731348

ABSTRACT

What covalent modifications control the temporal ubiquitination of ERα and hence the duration of its transcriptional activity remain poorly understood. We show that GREB1, an ERα-inducible enzyme, catalyzes O-GlcNAcylation of ERα at residues T553/S554, which stabilizes ERα protein by inhibiting association with the ubiquitin ligase ZNF598. Loss of GREB1-mediated glycosylation of ERα results in reduced cellular ERα levels and insensitivity to estrogen. Higher GREB1 expression in ERα+ve breast cancer is associated with greater survival in response to tamoxifen, an ERα agonist. Mice lacking Greb1 exhibit growth and fertility defects reminiscent of phenotypes in ERα-null mice. In summary, this study identifies GREB1, a protein with an evolutionarily conserved domain related to DNA-modifying glycosyltransferases of bacteriophages and kinetoplastids, as the first inducible and the only other (apart from OGT) O-GlcNAc glycosyltransferase in mammalian cytoplasm and ERα as its first substrate.


Subject(s)
Breast Neoplasms , Estrogen Receptor alpha , Membrane Proteins/metabolism , Animals , Breast Neoplasms/genetics , Breast Neoplasms/metabolism , Carrier Proteins/genetics , Estrogen Receptor alpha/genetics , Estrogen Receptor alpha/metabolism , Female , Gene Expression Regulation, Neoplastic , Glycosylation , Glycosyltransferases/genetics , Humans , Mammals/metabolism , Mice , Neoplasm Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...